Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced business and program updates ahead of upcoming investor ...

Company now expects to complete enrollment of 150 patients in Q2 2026, with a Phase 3 data readout in mid-2027; Rolling NDA ...

Genialis Expressions empowers drug development teams to make confident decisions by unifying workflows and standardizing omics data for enterprise-grade clarity and comparability across studiesBOSTON ...

Guests had an opportunity to meet Gabby Thomas, win health-focused prizes, and learn simple ways to take a more active role ...

Study met its primary endpoint demonstrating safety and tolerability of CMTX-101 in people with cystic fibrosisCMTX-101 ...

Consistent national recognition reflects a culture where employees thrive and patients benefit PALM SPRINGS, CALIFORNIA / ...

Asahi Kasei announced that ZOLL® Medical, an Asahi Kasei company, has launched the next-generation LifeVest® wearable ...

Seasoned healthcare entrepreneur with multiple exits strengthens governance as the company advances durable glaucoma gene ...

Together with cash on hand, the fully leveraged facility extends Aptevo's funding runway into 2029, enabling achievement of ...

Global MRI Market Expands Amid Rising Investments in Precision DiagnosticsThe Global MRI (Magnetic Resonance Imaging) Market ...

MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its ...